Short answer: weed can remain detectable for different lengths of time depending on the specimen, the test method, its cutoff, the amount and route of exposure, and your prior use. A urine result usually measures the metabolite THCCOOH rather than current impairment, so no calendar can tell you when your own result will turn negative.
| Most workplace-style urine question | Ask whether the program uses an immunoassay screen, confirmation, and which cutoff applies. |
| DOT urine cutoffs | 50 ng/mL for the initial immunoassay and 15 ng/mL for confirmation. |
| What a urine result means | It can reflect a measured metabolite meeting that program’s rule; it does not establish current impairment. |
| Best next step | Use the actual program’s instructions and, if helpful, a home test only as a personal screen—not a prediction of a laboratory outcome. |
Disclosure: This article may contain affiliate links. If you click a link and make a purchase, this site may receive a commission at no additional cost to you.
How THC is processed by your body
After cannabis exposure, testing may focus on a metabolite rather than the THC that caused the effects. In the controlled 2022 study of 21 infrequent users, researchers measured urine Δ9-THC-COOH after oral brownies and vaporized cannabis using immunoassay screens and LC-MS/MS confirmation. That is why the question is not simply “how long is THC in my body?” but “what analyte did this test measure, in which specimen, at what cutoff?”
Detection, impairment, and effects are separate questions. A urine metabolite result is not a measure of whether you are currently impaired. For the practical question of how long a cannabis experience may last, see how long do cannabis effects last.
THC detection windows by test type
The test you are facing matters more than a generic online range. The evidence below gives the actual specimen, assay, exposure pattern, collection times, and what the study observed. It is more useful than a personal deadline.
Urine: what one puff, one night, or occasional use can mean
Urine testing commonly looks for THCCOOH. A controlled study by Sholler and colleagues enrolled 21 infrequent cannabis users (11 men and 10 women; mean age 29 and mean BMI 26). On separate sessions, participants received 10 or 25 mg Δ9-THC brownies or vaporized 5 or 20 mg Δ9-THC cannabis. Urine was collected at baseline and 1, 2, 3, 4, 5, 6, and 8 hours.
| Evidence card | What it observed | What that means for you |
|---|---|---|
| Analyte and specimen Δ9-THC-COOH in urine |
DRI immunoassay cutoffs of 20, 50, and 100 ng/mL; LC-MS/MS confirmation criterion of at least 15 ng/mL. | A result depends on the exact screen and confirmation rule, not just whether you used cannabis. |
| Exposure and route Infrequent users; oral 10/25 mg or vaporized 5/20 mg Δ9-THC |
At active doses, Δ9-THC-COOH at or above 15 ng/mL appeared in 97.6% of oral sessions and 59.5% of vaporized sessions. With a 50 ng/mL screen plus confirmation, positives occurred in 97.6% of oral and 54.8% of vaporized sessions. | Edible and inhaled exposure can produce different observed urine patterns; the doses and routes were not matched for a direct route comparison. |
| Timing and limits Samples through 8 hours |
The study did not follow participants long enough to create a days-to-negative timetable. | For a puff, two puffs, one night, or twice-weekly use, a home result or a calendar cannot reliably predict a program result. |
That study is especially relevant to the “will one hit fail a drug test?” question because it shows that an acute exposure can produce urine positives under defined conditions. It cannot answer whether a particular puff, person, product, or testing program will produce a positive or negative result.
A second controlled study by Sholler and colleagues followed 18 healthy adults ages 18 to 45 after single CBD or CBD-dominant cannabis exposures, with serial urine collected through 58 hours. Pure CBD conditions did not produce Δ9-THCCOOH-positive tests in that study. After vaporized CBD-dominant cannabis containing 100 mg CBD plus 3.7 mg Δ9-THC, 3 of 18 participants produced six samples at or above 15 ng/mL; all six were positive at a 20 ng/mL immunoassay and two were positive at 50 ng/mL. The small, single-exposure study used controlled products and does not provide a personal end date; if a product contains Δ9-THC, treat its label and the actual test program as the relevant details.
Blood: a different specimen and question
A 2026 inpatient trial measured plasma THC, 11-OH-THC, and THC-COOH by LC-MS during seven days of abstinence in 46 adults, but its purpose was cannabis-withdrawal research, not a blood-test timetable. Plasma THC, 11-OH-THC, and THC-COOH fell from day 1 to day 3 by about 52%, 67%, and 65% across the cycling and stretching groups; cycling did not show a distinct cannabinoid advantage over stretching. That number describes the study group, not a blood-test prediction.
Saliva or oral fluid: ask the laboratory what it measures
Oral-fluid programs can use different analytes and cutoffs. A registered behavioral study in frequent young adult users lists THC, Δ8-THC, and CBD in oral fluid with a 1 ng/L cutoff, but it has no posted results and is not a consumer detection-window study. Ask the collector or program whether the test is oral fluid, what analyte and cutoff it uses, and whether there is a laboratory confirmation process. Our guide to types of drug tests for THC explains why specimen choice changes the question.
Hair: do not borrow a urine timeline
Hair testing is a separate method from urine testing. The evidence here does not provide a hair assay, cutoff, exposure study, or personal detection range, so a urine result should not be used to predict a hair result. Ask the testing program which hair method, segment length, analyte, and reporting rule it uses.
What do the cutoffs mean?
| Program or study | Specimen and method | Cutoff or criterion | Meaning |
|---|---|---|---|
| DOT-regulated transportation testing | Urine initial immunoassay | 50 ng/mL marijuana-metabolite initial cutoff | The federal initial-screen rule for this specific program. |
| DOT-regulated transportation testing | Urine confirmation | 15 ng/mL | Confirmation is a separate step from the initial immunoassay. |
| Sholler 2022 | Urine DRI immunoassay | 20, 50, and 100 ng/mL studied | Research cutoffs used to compare observations after defined oral and vaporized doses. |
| Sholler 2022 | Urine LC-MS/MS | At least 15 ng/mL confirmation criterion | Analytical confirmation criterion in that study. |
| Registered oral-fluid study | Saliva/oral fluid assay | 1 ng/L for THC, Δ8-THC, and CBD | A trial protocol’s listed assay cutoff, not a universal workplace standard. |
The DOT cutoff rule applies to federally regulated transportation testing, not every employer, school, clinic, or state program. Under DOT procedures, an initial urine immunoassay uses the 50 ng/mL cutoff and confirmation uses 15 ng/mL. A number such as “50” therefore cannot tell you how long it takes to go from 50 ng/mL to 20 ng/mL: the studies above do not establish a universal rate of decline, and the relevant result depends on the analyte, assay, specimen concentration, and program rule.
Why occasional and daily use are different questions
Prior use, dose, formulation, route, specimen, assay, and cutoff can all change observed results. The two Sholler studies were acute controlled studies in healthy screened adults or infrequent users; neither gives a days-to-negative range for daily use, chronic use, a high metabolism, or use after quitting. An observational study of adolescents and young adults followed biochemically verified abstinence for one month, showing why repeated-use questions need a different evidence base from a single-dose experiment.
Edibles and smoking or vaping also should not be treated as interchangeable. In Sholler 2022, oral brownies and vaporized cannabis had different doses and routes, and the investigators cautioned that the unequal doses prevent a formal route comparison. The useful takeaway is simple: tell the program or clinician about the product, route, and timing if those details are relevant; do not turn a general range into a deadline.
What about CBD, delta-8, and hemp products?
CBD and THC are analytically different. In the 18-person controlled Sholler study, pure CBD did not convert to Δ8- or Δ9-THC and did not produce Δ9-THCCOOH-positive urine tests under the study conditions. CBD-dominant cannabis containing a small amount of Δ9-THC produced measurable Δ9-THCCOOH in some participants.
Delta-8 adds another testing question. A 2023 analytical study found that Δ8-THC-COOH can cross-react with cannabinoid immunoassays and can interfere with chromatographic testing methods; the size of that effect depends on the method. A 2025 LC-MS/MS method-development study addressed separating Δ8 and Δ9 metabolite isomers. If your product was CBD, delta-8, or hemp-derived, do not assume the label alone resolves a workplace result—ask the program about its laboratory method and review process.
What if this is a DOT or workplace test?
For DOT-regulated transportation testing, follow the applicable DOT Part 40 procedures and your designated employer representative or Medical Review Officer (MRO). DOT rules provide an MRO interview route for a confirmed result and a split-specimen request route after notice of a verified positive or refusal because of adulteration or substitution. The split-specimen request is generally made within 72 hours of notification under 49 CFR §40.171.
A medical-marijuana recommendation, a hemp-related product, or a private negative test does not substitute for DOT Part 40 testing under 49 CFR §40.151. Other workplaces and states can use different rules. For the employment side of the decision, see whether you get fired for cannabis use under the rules that apply where you work; an employment lawyer can help with a state-specific dispute.
What can you actually do about a coming test?
There is no 100% way to promise that you will pass a drug test. The practical first step is to identify the actual testing program, specimen, screen and confirmation rule, and any MRO or review process. A home kit can be a personal screen, but it cannot stand in for a laboratory result unless its analyte, specimen, cutoff, collection, and confirmation context match.
Drinking extra water is not a reliable way to change THC elimination. A human workplace-specimen study found that fluid loading can alter urine characteristics, while workplace programs evaluate dilution and specimen validity. That is a specimen-validity issue, not a dependable clearance method. The same distinction applies to exercise: a 2026 randomized trial found no separate cycling advantage for plasma cannabinoids or withdrawal, and a small study in chronic daily users found no major urine or serum cannabinoid difference after exercise or food deprivation.
If you are looking at commercial options, compare the claims with the outcome you actually need. The THC detox products guide separates product claims from urine THCCOOH evidence and from screening-versus-confirmation questions. For a broader explanation of what matters in a testing situation, see how to pass a drug test for weed.
Do detox products change how long weed stays in your system?
Detoxify markets Mega Clean Herbal Cleanse in a 32-ounce bottle with Tropical Fruit flavor for $39.95, shown October 24, 2026. Its listed ingredients are burdock root extract, American ginseng root extract, guarana seed extract, milk thistle seed extract, stinging nettle leaf extract, taurine, and uva ursi leaf extract, as named on the seller’s page; the Supplement Facts image was not independently verified. Detoxify says it supports full-body cleansing, targets urinary, circulatory, and digestive systems, and has a three-to-four-hour optimal cleansing period; the same page says it is not designed for tests of any sort. Its FAQ describes a one-time-per-person replacement satisfaction guarantee for herbal cleanses rather than a stated cash refund.
Toxin Rid lists a 5 Day Extreme Cleanse / 5 Day Permanent Detox Kit at $109.95, shown October 24, 2026, with Pre-Rid capsules, Detox Liquid, Dietary Fiber, and one test strip. The maker describes it as a formulation for moderate-to-heavy users and says it starts working in one hour and provides complete detoxification in five days. Its published policy says sales are final and unused products are not accepted for return, subject to a narrow shipping-related exception. Toxin Rid’s 2 Day Detox Cleanse was shown at $59.95 with Pre-Rid capsules, Detox Liquid, Dietary Fiber, and one THC test strip; the maker says it is for light users and names a 50 ng/mL strip threshold.
These are maker statements, not a pass prediction. The controlled urine studies above measured defined cannabis exposures, assays, and cutoffs; they did not test either finished product for urine THCCOOH, a workplace screen, laboratory confirmation, or a test outcome. The 2025/2026 Cochrane review abstract states that no pharmacotherapies are currently approved specifically for cannabis use disorder; full-text certainty ratings were not extracted. Commercial cleanse products should not be presented as changing a test result on this basis.
Questions people ask before a test
How long should I stop smoking before a urine drug test?
No evidence here supports a personal stop-by date. The most decision-useful information is the test’s specimen, method, cutoff, and whether your exposure was a single controlled-like event or repeated use over time.
Will I pass if I smoked once two weeks ago?
No article can answer that for one person. A result requires an actual specimen measured by an actual program; a single-use study can show that acute exposure may produce positives under its stated conditions, not guarantee an outcome two weeks later.
Can clear urine or water make a test negative?
Fluid loading can change urine characteristics, and testing programs may assess specimen validity. It is not evidence of faster THC metabolite elimination or a reliable result.
What if I am trying to stop using cannabis, not just understand a test?
Withdrawal and metabolite detection are different questions. The 2026 inpatient trial measured withdrawal and plasma markers during abstinence, and the 2025/2026 Cochrane review found no approved medication specifically for cannabis use disorder. A clinician can help with care for stopping use; that is separate from a testing deadline.
Before you order a home test or detox product
- Ask which specimen, analyte, method, cutoff, and confirmation procedure your actual program uses.
- Read a home kit’s label to see whether its specimen and cutoff match the question you are trying to answer.
- Read the seller’s current label, price, shipping, and refund terms before purchasing; prices shown above were displayed October 24, 2026 and can change.
- For a DOT result, use the designated MRO and written process, including the split-specimen route where applicable.
